Alvotech (ALVO) Divestments (2024 - 2025)
Alvotech (ALVO) posted Divestments of $9.0 million for Q3 2025, up 203.36% on a QoQ basis from $3.0 million in Q1 2025, and down 24.79% year-over-year from $12.0 million in Q3 2024.
Alvotech (ALVO) Divestments (2024 - 2025) Analysis & Trends
Alvotech's Divestments history runs 2 years deep, the most recent figure standing at $9.0 million for Q3 2025.
- Quarterly Divestments fell 24.79% year-over-year to $9.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $24.0 million (changed N/A YoY) and the FY2020 annual result came in at -$5.0 million, changed 0.0% from the prior year.
- Divestments was $9.0 million for Q3 2025 at Alvotech, up from $3.0 million in the prior quarter.
- Across five years, Divestments topped out at $12.0 million in Q3 2024 and bottomed at $3.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 42.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.28 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |